Bionano Genomics IncChange company Symbol lookupSelect an option...BNGO Bionano Genomics IncSNCY Sun Country Airlines Holdings IncNCZ Virtus Convertible & Income Fund IIXPEV Xpeng IncPTON Peloton Interactive IncPEB Pebblebrook Hotel TrustVFC VF CorpBWG BrandywineGLOBAL ? Global Income Opportunities FundBPYPO Brookfield Property Partners LPHLAHU Hamilton Lane Alliance Holdings I IncGo
Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
Company Profile
Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.
Valuation Ratios
- Price/Earnings (TTM)
- --
- Price/Sales (TTM)
- 23.05x
- Price/Book (MRQ)
- 2.12x
- Price/Cash Flow (TTM)
- --
MRQ = Most Recent Quarter
Price Performance
Financial Statements
Balance sheet
Values displayed are in thousands.
Income statement
Values displayed are in thousands.
Cash flow
Values displayed are in thousands.
Company Officers
- David L. Barker
- R. Erik HolmlinPres.
- Christopher P StewartCFO
- Mark OldakowskiCOO
- Helene Klein
Address
- 9640 Towne Centre Drive
- San Diego, CA 92121
- Phone: (858) 888-7600
- Fax: (858) 888-7601
- https://bionanogenomics.com/
Insider Trading
During the most recent quarter, 20K shares were sold in insider trading.
Insider trading information report provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.